NCT00279760 Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT00279734 Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00279409 Treatment of Children With ADHD Who do Not Fully Respond to Stimulants Status TERMINATED Phase PHASE2
NCT00277225 A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris Status COMPLETED Phase PHASE1
NCT00272779 BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada Status COMPLETED Phase PHASE3
NCT00270712 A Study of Factors That Affect Long-Term Kidney Transplant Function Status COMPLETED Phase N/A
NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00264212 AMISH : Aprovel for Management of Isolated Systolic Hypertension Status COMPLETED Phase PHASE4
NCT00263276 A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00261365 Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) Status COMPLETED Phase PHASE1/PHASE2
NCT00258921 RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment Status COMPLETED Phase N/A
NCT00256750 Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) Status COMPLETED Phase PHASE3
NCT00255346 Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Status COMPLETED Phase PHASE2
NCT00254293 Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1/PHASE2
NCT00252564 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3